Cordatus Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$731K Buy
8,136
+684
+9% +$64.2K 0.28% 117
2020
Q4
$689K Buy
7,452
+240
+3% +$21.4K 0.29% 105
2020
Q3
$743K Buy
7,212
+40
+0.6% +$4.18K 0.36% 95
2020
Q2
$727K Sell
7,172
-6,280
-47% -$562K 0.4% 85
2020
Q1
$906K Buy
+13,452
New +$837K 0.65% 62

Other funds holding DXCM

Cordatus Wealth Management's DXCM Position: Q1 2021 in Review

Cordatus Wealth Management increased its DexCom (DXCM) stake by 9.2% in Q1 2021, buying an estimated $64.2K and bringing the position to 8,136 shares worth $731K. The position accounts for 0.28% of the portfolio, ranked #117.

Cordatus Wealth Management first reported a position in DXCM in Q1 2020 and has held it in 5 quarters since. The position peaked at $906K in Q1 2020. 729 funds tracked by Wall St. Rank hold DXCM as of Q1 2021.

  • Cordatus Wealth Management held 8,136 shares of DexCom worth $731K as of Q1 2021.
  • Cordatus Wealth Management bought 684 DexCom shares in Q1 2021, an estimated $64.2K.
  • DexCom made up 0.28% of Cordatus Wealth Management's portfolio in Q1 2021, its #117 holding.
  • Cordatus Wealth Management first reported a position in DexCom in Q1 2020 and has held it in 5 quarters since.
  • Cordatus Wealth Management's DexCom position peaked at $906K in Q1 2020.
  • 729 funds tracked by Wall St. Rank held DexCom as of Q1 2021.

Based on Cordatus Wealth Management's 13F filing for Q1 2021, filed 26 Apr 2021.